217 related articles for article (PubMed ID: 23696194)
1. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Luhn P; Dallal CM; Weiss JM; Black A; Huang WY; Lacey JV; Hayes RB; Stanczyk FZ; Wentzensen N; Brinton LA
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1304-12. PubMed ID: 23696194
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
[TBL] [Abstract][Full Text] [Related]
4. Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.
Trabert B; Coburn SB; Falk RT; Manson JE; Brinton LA; Gass ML; Kuller LH; Rohan TE; Pfeiffer RM; Qi L; Stefanick ML; Wentzensen N; Anderson GL; Xu X
Cancer Causes Control; 2019 Nov; 30(11):1201-1211. PubMed ID: 31542834
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer and adipokines.
Pérez-López FR
Climacteric; 2013 Dec; 16(6):725-6. PubMed ID: 24383095
[No Abstract] [Full Text] [Related]
6. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
[TBL] [Abstract][Full Text] [Related]
7. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
[TBL] [Abstract][Full Text] [Related]
8. Case-control study of endogenous steroid hormones and endometrial cancer.
Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
[TBL] [Abstract][Full Text] [Related]
9. Adipokines linking obesity with colorectal cancer risk in postmenopausal women.
Ho GY; Wang T; Gunter MJ; Strickler HD; Cushman M; Kaplan RC; Wassertheil-Smoller S; Xue X; Rajpathak SN; Chlebowski RT; Vitolins MZ; Scherer PE; Rohan TE
Cancer Res; 2012 Jun; 72(12):3029-37. PubMed ID: 22511581
[TBL] [Abstract][Full Text] [Related]
10. Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT Cohort.
Dallal CM; Lacey JV; Pfeiffer RM; Bauer DC; Falk RT; Buist DS; Cauley JA; Hue TF; LaCroix AZ; Tice JA; Veenstra TD; Xu X; Brinton LA;
Horm Cancer; 2016 Feb; 7(1):49-64. PubMed ID: 26728471
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
[TBL] [Abstract][Full Text] [Related]
13. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
[TBL] [Abstract][Full Text] [Related]
14. Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.
Dimou NL; Papadimitriou N; Mariosa D; Johansson M; Brennan P; Peters U; Chanock SJ; Purdue M; Bishop DT; Gago-Dominquez M; Giles GG; Moreno V; Platz EA; Tangen CM; Wolk A; Zheng W; Wu X; Campbell PT; Giovannucci E; Lin Y; ; Gunter MJ; Murphy N
Int J Cancer; 2021 Apr; 148(7):1625-1636. PubMed ID: 33038280
[TBL] [Abstract][Full Text] [Related]
15. Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study.
Playdon MC; Coburn SB; Moore SC; Brinton LA; Wentzensen N; Anderson G; Wallace R; Falk RT; Pfeiffer R; Xu X; Trabert B
Br J Cancer; 2018 Feb; 118(3):448-457. PubMed ID: 29235567
[TBL] [Abstract][Full Text] [Related]
16. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
17. Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Lang Kuhs KA; Hildesheim A; Trabert B; Kemp TJ; Purdue MP; Wentzensen N; Katki HA; Pinto LA; Loftfield E; Safaeian M; Chaturvedi AK; Shiels MS
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):825-32. PubMed ID: 25713025
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
[TBL] [Abstract][Full Text] [Related]
19. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?
Gaudet MM; Falk RT; Gierach GL; Lacey JV; Graubard BI; Dorgan JF; Brinton LA
Cancer Epidemiol; 2010 Oct; 34(5):580-6. PubMed ID: 20579950
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
